Goldman Sachs’s OrthoPediatrics KIDS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$5.43M Buy
342,443
+168,297
+97% +$2.94M ﹤0.01% 3613
2025
Q4
$3.09M Buy
174,146
+92,254
+113% +$1.62M ﹤0.01% 4203
2025
Q3
$1.52M Buy
81,892
+14,188
+21% +$292K ﹤0.01% 4715
2025
Q2
$1.45M Sell
67,704
-132,735
-66% -$2.87M ﹤0.01% 4421
2025
Q1
$4.94M Buy
200,439
+106,041
+112% +$2.62M ﹤0.01% 3366
2024
Q4
$2.19M Buy
94,398
+20,942
+29% +$524K ﹤0.01% 4196
2024
Q3
$1.99M Sell
73,456
-830
-1% -$25.1K ﹤0.01% 4160
2024
Q2
$2.14M Buy
74,286
+48,580
+189% +$1.49M ﹤0.01% 3869
2024
Q1
$750K Sell
25,706
-72,211
-74% -$2.02M ﹤0.01% 4525
2023
Q4
$3.18M Buy
97,917
+42,542
+77% +$1.23M ﹤0.01% 3558
2023
Q3
$1.77M Buy
55,375
+486
+0.9% +$18.7K ﹤0.01% 3860
2023
Q2
$2.41M Sell
54,889
-2,098
-4% -$96.7K ﹤0.01% 3719
2023
Q1
$2.52M Buy
56,987
+13,591
+31% +$601K ﹤0.01% 3682
2022
Q4
$1.72M Sell
43,396
-34,264
-44% -$1.43M ﹤0.01% 4047
2022
Q3
$3.58M Buy
77,660
+61,044
+367% +$2.99M ﹤0.01% 3442
2022
Q2
$717K Buy
16,616
+7,175
+76% +$328K ﹤0.01% 4844
2022
Q1
$510K Sell
9,441
-842
-8% -$43K ﹤0.01% 5303
2021
Q4
$616K Sell
10,283
-3,580
-26% -$223K ﹤0.01% 5231
2021
Q3
$908K Buy
13,863
+5,590
+68% +$363K ﹤0.01% 4823
2021
Q2
$523K Buy
8,273
+1,955
+31% +$112K ﹤0.01% 5183
2021
Q1
$308K Buy
6,318
+1,430
+29% +$68.6K ﹤0.01% 5418
2020
Q4
$202K Sell
4,888
-8,580
-64% -$393K ﹤0.01% 5087
2020
Q3
$618K Buy
13,468
+7,807
+138% +$362K ﹤0.01% 4366
2020
Q2
$248K Sell
5,661
-9,889
-64% -$445K ﹤0.01% 4709
2020
Q1
$616K Sell
15,550
-7,780
-33% -$349K ﹤0.01% 4083
2019
Q4
$1.1M Buy
+23,330
New +$904K ﹤0.01% 4065
2019
Q2
Sell
-8,483
Closed -$375K 5248
2019
Q1
$375K Buy
+8,483
New +$323K ﹤0.01% 4536

Other funds holding KIDS

Goldman Sachs's KIDS Position: Q1 2026 in Review

Goldman Sachs increased its OrthoPediatrics (KIDS) stake by 97% in Q1 2026, buying an estimated $2.94M and bringing the position to 342,443 shares worth $5.43M. The position accounts for ﹤0.01% of the portfolio, ranked #3613.

Goldman Sachs first reported a position in KIDS in Q1 2019 and has held it in 27 quarters since. 121 funds tracked by Wall St. Rank hold KIDS as of Q1 2026.

  • Goldman Sachs held 342,443 shares of OrthoPediatrics worth $5.43M as of Q1 2026.
  • Goldman Sachs bought 168,297 OrthoPediatrics shares in Q1 2026, an estimated $2.94M.
  • OrthoPediatrics made up ﹤0.01% of Goldman Sachs's portfolio in Q1 2026, its #3613 holding.
  • Goldman Sachs first reported a position in OrthoPediatrics in Q1 2019 and has held it in 27 quarters since.
  • 121 funds tracked by Wall St. Rank held OrthoPediatrics as of Q1 2026.

Based on Goldman Sachs's 13F filing for Q1 2026, filed 15 May 2026.